Persistence Within 6P Medicine Model Has Value for Clinical Decision Only When Adherence Is Assessed

Abstract

Get full access to this article

View all access options for this article.

References

Borrás-Blasco

Ramírez-Herráiz

Navarro-Ruiz

Integration of persistence in the 5P-medicine approach for age-related chronic diseases. Int J Qual Health Care. 2024;36(2):mzae026. doi:10.1093/intqhc/mzae026

Rodriguez Goicoechea

Tejedor

Tejada E

Borrás Blasco

. Persistence, current state of the art. Farm Hosp. 2024;48:141. doi:10.1016/j.farma.2023.07.015

Megeed

Magas

Accursi

Burant

Hansen

The impact of a pharmacist-led oral anticancer clinic on medication adherence and laboratory monitoring. J Oncol Pharm Pract. 2023;29(8):1921-1927. doi:10.1177/10781552231159870

Borrás-Blasco

Cornejo

Valcuende-Rosique

, et al. Persistence after switching from adalimumab biosimilar MSB11022 to adalimumab biosimilar GP2017 in patients with chronic inflammatory rheumatic diseases. J Pharm Technol. 2024;40(2):123-130.

Borrás-Blasco

Cornejo

Valcuende-Rosique

, et al. Long-term persistence with secukinumab in patients with moderate-to-severe psoriasis. Farm Hosp. 2025;49(1):45-52.

Borrás-Blasco

Alcala

Valcuende-Rosique

Cornejo

Long-term real-world persistence of guselkumab in patients with moderate-to-severe psoriasis. Actas Dermosifiliogr. in press.

Bogusz

Sucala

Applebaum

, et al. Variants and determinants of unintentional and intentional medication nonadherence: a systematic review.  Patient Prefer Adherence. 2024;18:1121-1136. doi:10.2147/PPA.S432100

Pina

Donato

Cabral

Lopes

Treatment persistence and switching patterns of biologics in patients with psoriatic arthritis: a real-world analysis. Clin Rheumatol. 2023;42(4):1237-1245. doi:10.1007/s10067-022-06446-w

Feldman

Bohn

Gao

, et al. Poor adherence to and persistence with biologics in generalized pustular psoriasis: a claims based study using real‑world data from two large US databases. JAAD Int. 2024;15:78-83. doi:10.1016/j.jdin.2023.12.008